Active Implantable Medical Devices (AIMDs) are devices which are implanted in a human body. These devices are required to comply with European Directives such as the Medical Device Regulation (EU) 2017/745. UK-based manufacturers of AIMDs must comply with the requirements of Part III of the Medical Devices Regulations (MDR) 2002. Working with an approved body is crucial to ensure that a device meets these regulatory requirements and is ready for the market. One of the major drivers of the market growth is the increasing geriatric population. The world’s population is expected to increase by 2 billion persons in the next 30 years, from 7.7 billion currently to 9.7 billion in 2050, according to the United Nations. Other factors driving the growth of the market include the prevalence of chronic diseases and the rising demand for non-invasive procedures.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/1126
In addition, the active implantable medical devices includes accessories, as well as non-implantable parts. All of these components must meet specific standards in order to be considered safe for use in humans.
Advancements in technology in active implantable medical devices such as MRI compatible pacemakers and cochlear implants with smartphone connectivity is expected to be a major driving factor propelling demand for active implantable medical devices over the forecast period. Key players are focusing on upgrading the available implantable medical devices as well as developing new devices for various acute conditions related to diseases such as cardiovascular and neurological. For instance, in January 2019, Medtronic, whose founder invented some of the earliest pacemakers, said it has launched a mobile app that for the first time enables a portfolio of pacemakers to communicate directly with patients’ smartphones and tablets. Furthermore, in 2016, Boston Scientific Corporation was successful in receiving approval for its EMBLEM MRI subcutaneous implantable cardioverter defibrillator (ICD) system. Biotronik received approval for its leadless ICD system, which is first of its kind, in the U.S. in July 2017. Moreover, in 2016, Medtronic plc was the first company to receive FDA approval for magnetic resonance imaging (MRI) conditional cardiac resynchronization therapy devices (CRT-D), and was also successful in receiving approval from FDA for MR-Conditional Quadripolar CRT-P in May 2017. In 2016, St. Jude Medical launched its first commercial implants of dorsal root ganglion (DRG) stimulation therapy for management of chronic intractable pain in the U.S. Furthermore, Cochlear Limited launched iPhone compatible cochlear implant in July 2017. Abbott announced European CE mark approval for world’s first smartphone compatible Confirm Rx insertable cardiac monitor in October 2017.
Key manufacturers are investing heavily in developing advanced implantable medical devices to monitor vital organs and capability of their functioning. Medtronic plc received the U.S. FDA approval for its portfolio of Azure pacemakers with BlueSync technology in November 2017. This technology-enabled secure, automatic, and wireless remote monitoring via the Medtronic CareLink Network making remote patient monitoring possible in case of pacemakers. Furthermore, research organizations are focusing on developing batteryless pacemakers. For instance, researchers from Rice University and Texas Heart Institute (THI) introduced a wireless, and batteryless pacemaker that can directly be implanted into a patient’s heart, in June 2017. Furthermore, Glenfield Hospital, U.K. is focusing on developing a new technique for fitting pacemakers in patients under HOPE-HF clinical trials, which involves placing an extra pacemaker wire into the heart to correct delays in electrical activation. The clinical trials as a part of the His Optimized Pacing Evaluated for Heart Failure Trial (HOPE-HF) are being conducted throughout the country.
Key Takeaways of the Active Implantable Medical Devices Market:
- The global active implantable medical devices market is expected to exhibit a CAGR of 5.4% over the forecast period (2017–2025), owing to presence of high potential markets, especially in Asia Pacific, Latin America, Middle East, and Africa. Multiple product launches from leading players such as Medtronic plc. and St. Jude Medical, Inc and growing number of innovative start-ups in the field in these regions in recent years is has led to development of cost-effective products, which in turn has resulted in higher adoption rate for the technology
- Strong competition in the market spurs the demand for continuous development from supply as well as demand side as manufacturers thrive to stay competitive in the market and customers remain on the lookout for the alternatives boosting the development rate in active implantable medical devices market driving growth of the global active implantable medical devices market
- Implantable Neurostimulators product type segment is projected to show significant growth due to growing application in management of chronic pain diseases
- Asia Pacific region is expected to show significant growth owing to multiple product launches by major players such as launch of Edora pacemakers by Biotronik in Japan in 2017
- According to WHO, 31% (about 17.7 million) of all global deaths were due to cardiovascular diseases (CVDs) and this number is expected to grow further as aging population, which are more prone to CVDs is growing. Growing prevalence of cardiovascular diseases, which can be monitored or treated by devices such as pacemakers and ICDs, is expected to be the major factors driving growth of the global active implantable medical devices market over the forecast period
- Key players involved in the active implantable medical devices market include Cochlear Limited, Boston Scientific Corporation, Medtronic Plc, LivaNova Plc, Abbott Laboratories, Sonova Holding AG, William Demant holding A/S, Nurotron Biotechnology Co., Ltd., and Med-EL
Request Here PDF Brochure Of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1126
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Active Implantable Medical Devices Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Active Implantable Medical Devices Industry Impact
Chapter 2 Global Active Implantable Medical Devices Competition by Types, Applications, and Top Regions and Countries
2.1 Global Active Implantable Medical Devices (Volume and Value) by Type
2.3 Global Active Implantable Medical Devices (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Active Implantable Medical Devices Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Active Implantable Medical Devices Market Analysis
Chapter 6 East Asia Active Implantable Medical Devices Market Analysis
Chapter 7 Europe Active Implantable Medical Devices Market Analysis
Chapter 8 South Asia Active Implantable Medical Devices Market Analysis
Chapter 9 Southeast Asia Active Implantable Medical Devices Market Analysis
Chapter 10 Middle East Active Implantable Medical Devices Market Analysis
Chapter 11 Africa Active Implantable Medical Devices Market Analysis
Chapter 12 Oceania Active Implantable Medical Devices Market Analysis
Chapter 13 South America Active Implantable Medical Devices Market Analysis
Chapter 14 Company Profiles and Key Figures in Active Implantable Medical Devices Business
Chapter 15 Global Active Implantable Medical Devices Market Forecast (2022-2028)
Chapter 16 Conclusions
Research Methodology
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/1126
About US
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com